Skip to main navigation Skip to search Skip to main content

Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial

  • Michael D. Ezekowitz
  • , Charles V. Pollack
  • , Paul Sanders
  • , Jonathan L. Halperin
  • , Judith Spahr
  • , Nilo Cater
  • , William Petkun
  • , Andrei Breazna
  • , Paulus Kirchhof
  • , Jonas Oldgren

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Nursing and Health Professions

Medicine and Dentistry